查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2040575

腎臟和泌尿系統醫療設備市場規模、佔有率和趨勢分析報告：按產品、應用、最終用途、地區和細分市場分類（2026-2033 年）

Nephrology And Urology Devices Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

腎臟和泌尿系統醫療設備市場概況。

2025年全球腎臟和泌尿系統醫療設備市場規模估計為67.3億美元，預計到2033年將達到117.3億美元。

預計從 2026 年到 2033 年，其複合年成長率將達到 7.26%。這一成長是由慢性腎臟病、尿道結石和泌尿器官系統癌症盛行率上升，以及糖尿病和高血壓負擔加重所驅動的，這些因素都會導致長期腎臟併發症。

微創和內視鏡泌尿系統手術（包括先進的導尿術、支架置入術和結石治療技術）的日益普及，進一步推動了對專用醫療設備的需求。此外，醫療基礎設施的不斷改進、泌尿系統診斷和治療服務的可近性提高，以及生物材料和醫療設備設計的持續創新，都促進了手術效率的提升和病患預後的改善。門診和日間手術的興起，以及人們對早期診斷和治療意識的增強，也推動了市場的持續成長。

泌尿器官系統和腎臟疾病的日益普遍是腎臟和泌尿系統醫療設備市場成長的主要驅動力。慢性腎臟病、腎結石和良性前列腺增生等疾病的發生率因人口老化、久坐的生活方式、糖尿病和高血壓等因素而不斷上升。隨著這些疾病的進展，持續的臨床管理變得至關重要，這也增加了對各種醫療設備的需求。例如，慢性腎臟病（CKD）患者最終會發展為末期腎功能衰竭，需要使用透析機、透析器和靜脈通路裝置進行長期透析治療。

隨著腎結石發生率的上升，輸尿管鏡等泌尿系統視鏡手術的數量也在增加，而這些手術高度依賴輸尿管導管、導管導引線和取石系統等醫療設備。良性前列腺增生（BPH）和其他下泌尿道疾病患者數量的增加也推動了導管、支架和微創治療醫療設備的使用。此外，由於許多此類疾病具有慢性復發性，反覆手術和醫療設備的長期使用導致市場整體需求顯著成長。持續成長的患者群體導致手術數量增加和一次性醫療設備的持續消耗，疾病流行是市場成長的主要驅動力。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 腎臟和泌尿系統醫療設備市場：變數、趨勢和範圍

  • 市場譜系展望
  • 以使用者觀點的分析
  • 市場動態
  • 用於腎臟和泌尿系統的醫療設備市場分析工具。

第4章 腎臟和泌尿系統醫療設備市場：產品特定估算和趨勢分析

  • 定義和範圍
  • 按產品分類的市場佔有率，2021 年和 2033 年
  • 全球腎臟和泌尿系統醫療設備市場：按產品分類，展望。
  • 市場規模、預測與趨勢分析（2025-2033年）
    • 輸尿管
    • PCN導管
    • 泌尿道支架
    • Stone Basket
    • 泌尿系統導管導引線
    • 腎擴張器
    • 其他

第5章 腎臟和泌尿系統醫療設備市場：按應用分類的估算和趨勢分析

  • 定義和範圍
  • 按應用領域分類的市場佔有率，2021 年和 2033 年
  • 全球腎臟和泌尿系統醫療設備市場：按應用領域分類，展望。
  • 市場規模、預測與趨勢分析（2025-2033年）
    • 尿道結石
    • 泌尿系統癌症和良性前列腺增生（BPH）
    • 膀胱疾病
    • 腎臟疾病
    • 其他

第6章 腎臟和泌尿系統醫療設備市場：按最終用途分類的估算和趨勢分析

  • 定義和範圍
  • 按最終用途分類的市場佔有率，2021 年和 2033 年
  • 全球腎臟和泌尿系統醫療設備市場：按最終用途分類，展望。
  • 市場規模、預測與趨勢分析（2025-2033年）
    • 醫院
    • 診所
    • 門診手術中心
    • 其他

第7章 腎臟和泌尿系統醫療設備市場：區域估算和趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 全球市場概述（按地區分類）
  • 2025年區域市佔率及主要公司
  • 市場應用、預測與趨勢分析（2021年至2033年）：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業近期趨勢及影響分析
  • 公司和競爭對手的分類
    • 創新者
  • 銷售代理商名單
  • 供應商情況
    • 主要銷售代理商和通路夥伴名單
    • Key customers
    • Region wise key company market share analysis, 2025
    • Hollister Incorporated
    • Coloplast
    • Boston Scientific Corporation
    • B. Braun SE
    • Teleflex Incorporated
    • Baxter
    • Fresenius Medical Care AG & Co.
    • Asahi Kasei Corporation
    • Cook Group
    • Terumo Corporation
    • Nipro Medical Corporation
    • BD
    • Olympus
    • Allium Medical
    • Pnn Medical A/S
    • Merit Medical Systems（BioLife Plasma Services）
    • Convatec
    • Ur24Technology, Inc.
    • Sterimed Group
    • Wellspect HealthCare, a Dentsply Sirona Company
    • Boehringer Laboratories, LLC
    • Medline Industries, LP.
Product Code: GVR-1-68038-090-3

Nephrology & Urology Devices Market Summary

The global nephrology and urology devices market size was estimated at USD 6.73 billion in 2025 and is projected to reach USD 11.73 billion by 2033, growing at a CAGR of 7.26% from 2026 to 2033. This growth is driven by the rising prevalence of chronic kidney disease, urolithiasis, and urinary system cancers, along with the increasing burden of diabetes and hypertension that contribute to long-term renal complications.

The growing adoption of minimally invasive and endourological procedures, including advanced catheterization, stenting, and stone management techniques, is further accelerating demand for specialized devices. In addition, expanding healthcare infrastructure, improved access to diagnostic and interventional urology services, and continuous innovation in biomaterials and device design are supporting procedural efficiency and patient outcomes. The shift toward outpatient and ambulatory surgical care, combined with increasing awareness of early diagnosis and treatment, is also contributing to sustained market expansion.

The rising prevalence of urological and renal disorders is a primary driver of growth in the nephrology and urology devices market. Conditions such as chronic kidney disease, kidney stones, and benign prostatic hyperplasia are increasing due to aging populations, sedentary lifestyles, diabetes, and hypertension. As these diseases progress, they require continuous clinical management, thereby increasing demand for a wide range of medical devices. For instance, CKD patients progress to end-stage renal disease, necessitating long-term dialysis supported by machines, dialyzers, and vascular access devices.

The growing incidence of kidney stones has led to a greater number of endourological procedures, such as ureteroscopy, which rely heavily on devices such as ureteral catheters, guidewires, and stone retrieval systems. In the case of BPH and other lower urinary tract disorders, increased patient volumes are driving the use of catheters, stents, and minimally invasive treatment devices. In addition, many of these conditions are chronic and recurrent, leading to repeated procedures and long-term device use, which significantly increases overall market demand. This sustained and expanding patient pool translates into higher procedural volumes and continuous consumption of disposable devices, making disease prevalence a key growth engine for the market.

Global Nephrology And Urology Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global nephrology And urology devices market report based on product, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Ureteral Catheters
    • Intermittent Catheters
    • Foley / Indwelling Catheters
    • External Catheters
  • PCN Catheters
  • Urinary Stents
    • Metallic Ureteral Stents
    • Polymer Ureteral Stents
    • Silicone Stents
    • Polyurethane Stents
    • Hybrid Stents
  • Stone Basket
    • Disposable
    • Reusable
  • Urology Guidewires
    • Nitinol Guidewires
    • Stainless Steel Guidewires
    • PTFE Guidewires
    • Others
  • Renal Dilators
    • Disposable
    • Reusable
  • Other
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Urolithiasis
  • Urological Cancer & BPH
  • Bladder Disorders
  • Kidney Diseases
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Third Party Perspective
    • 1.3.5. Primary research
    • 1.3.6. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights Outlook

Chapter 3. Nephrology and Urology Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Related/ancillary market outlook.
  • 3.2. User Perspective Analysis
    • 3.2.1. Consumer behavior analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Rising prevalence of urological and renal disorders
      • 3.3.1.2. Increase in minimally invasive procedures
      • 3.3.1.3. Favorable reimbursement framework
      • 3.3.1.4. Technological advancements
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Strict reimbursement policies and quantity limits
      • 3.3.2.2. Pricing pressure
      • 3.3.2.3. Risk of infections and complications
    • 3.3.3. Market opportunities analysis
      • 3.3.3.1. Expansion of home healthcare segment and remote patient monitoring
      • 3.3.3.2. Innovation in minimally invasive therapies
      • 3.3.3.3. Untapped potential in female urology devices
      • 3.3.3.4. Emerging technologies in robotic urology and smart drainage systems
    • 3.3.4. Market challenges analysis
      • 3.3.4.1. Supply chain disruptions
      • 3.3.4.2. Training requirements for advanced urology and dialysis devices
      • 3.3.4.3. Competition from low-cost alternatives and commoditization of consumables
  • 3.4. Nephrology and Urology Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Nephrology and Urology Devices Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Product Market Share, 2021 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Nephrology & Urology Devices Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following
    • 4.5.1. Ureteral Catheters
      • 4.5.1.1. Ureteral catheters market estimates and forecast 2021 to 2033 (USD Million, Volume Unit)
      • 4.5.1.2. Intermittent Catheters
      • 4.5.1.3. Foley/ Indwelling Catheters
      • 4.5.1.4. External Catheters
    • 4.5.2. PCN Catheters
      • 4.5.2.1. PCN catheters market estimates and forecast 2021 to 2033 (USD Million, Volume Unit)
    • 4.5.3. Urinary Stents
      • 4.5.3.1. Urinary stents market estimates and forecast 2021 to 2033 (USD Million, Volume Unit)
      • 4.5.3.2. Metallic Ureteral Stents
      • 4.5.3.3. Polymer Ureteral Stents
        • 4.5.3.3.1. Silicone Stents
        • 4.5.3.3.2. Polyurethane Stents
        • 4.5.3.3.3. Hybrid Stents
    • 4.5.4. Stone Basket
      • 4.5.4.1. Stone basket market estimates and forecast 2021 to 2033 (USD Million, Volume Unit)
      • 4.5.4.2. Disposable
      • 4.5.4.3. Reusable
    • 4.5.5. Urology Guidewires
      • 4.5.5.1. Urology guidewires market estimates and forecast 2021 to 2033 (USD Million, Volume Unit)
      • 4.5.5.2. Nitinol Guidewires
      • 4.5.5.3. Stainless Steel Guidewires
      • 4.5.5.4. PTEE Guidewires
      • 4.5.5.5. Others
    • 4.5.6. Renal Dilators
      • 4.5.6.1. Renal dilators market estimates and forecast 2021 to 2033 (USD Million, Volume Unit)
      • 4.5.6.2. Disposable
      • 4.5.6.3. Reusable
    • 4.5.7. Other
      • 4.5.7.1. Other market estimates and forecast 2021 to 2033 (USD Million, Volume Unit)

Chapter 5. Nephrology & Urology Devices Market: Application Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Application Market Share, 2021 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Nephrology & Urology Devices Market by Application Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following
    • 5.5.1. Urolithiasis
      • 5.5.1.1. Urolithiasis market estimates and forecast 2021 to 2033 (USD Million)
    • 5.5.2. Urological Cancer & BPH
      • 5.5.2.1. Urological cancer & BPH market estimates and forecast 2021 to 2033 (USD Million)
    • 5.5.3. Bladder Disorders
      • 5.5.3.1. Bladder disorders market estimates and forecast 2021 to 2033 (USD Million)
    • 5.5.4. Kidney Diseases
      • 5.5.4.1. Kidney diseases market estimates and forecast 2021 to 2033 (USD Million)
    • 5.5.5. Other
      • 5.5.5.1. Other market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Nephrology & Urology Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. End Use Market Share, 2021 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Global Nephrology & Urology Devices Market by End Use Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following
    • 6.5.1. Hospitals
      • 6.5.1.1. Hospitals market estimates and forecast 2021 to 2033 (USD Million)
    • 6.5.2. Clinics
      • 6.5.2.1. Clinics market estimates and forecast 2021 to 2033 (USD Million)
    • 6.5.3. Ambulatory Surgical Centers
      • 6.5.3.1. Ambulatory Surgical Centers market estimates and forecast 2021 to 2033 (USD Million)
    • 6.5.4. Other
      • 6.5.4.1. Other market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Nephrology & Urology Devices Market: Regional Estimates & Trend Analysis by Product, Application, End Use

  • 7.1. Regional market share analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2025
  • 7.5. Market Application, & Forecasts and Trend Analysis, 2021 to 2033:
  • 7.6. North America
    • 7.6.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
    • 7.6.2. U.S.
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. U.S. market estimates and forecasts, 2021 - 2033
    • 7.6.3. Canada
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Canada market estimates and forecasts, 2021 - 2033
    • 7.6.4. Mexico
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. Mexico market estimates and forecasts, 2021 - 2033
  • 7.7. Europe
    • 7.7.1. Germany
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement scenario
      • 7.7.1.5. Germany market estimates and forecasts, 2021 - 2033
    • 7.7.2. UK
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. UK market estimates and forecasts, 2021 - 2033
    • 7.7.3. France
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. France market estimates and forecasts, 2021 - 2033
    • 7.7.4. Italy
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. Italy market estimates and forecasts, 2021 - 2033
    • 7.7.5. Spain
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. Spain market estimates and forecasts, 2021 - 2033
    • 7.7.6. Denmark
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Denmark market estimates and forecasts, 2021 - 2033
    • 7.7.7. Sweden
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Competitive scenario
      • 7.7.7.3. Regulatory framework
      • 7.7.7.4. Reimbursement scenario
      • 7.7.7.5. Sweden market estimates and forecasts, 2021 - 2033
    • 7.7.8. Norway
      • 7.7.8.1. Key country dynamics
      • 7.7.8.2. Competitive scenario
      • 7.7.8.3. Regulatory framework
      • 7.7.8.4. Reimbursement scenario
      • 7.7.8.5. Norway market estimates and forecasts, 2021 - 2033
  • 7.8. Asia Pacific
    • 7.8.1. China
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement scenario
      • 7.8.1.5. China market estimates and forecasts, 2021 - 2033
    • 7.8.2. Japan
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. Japan market estimates and forecasts, 2021 - 2033
    • 7.8.3. India
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. India market estimates and forecasts, 2021 - 2033
    • 7.8.4. Australia
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. Australia market estimates and forecasts, 2021 - 2033
    • 7.8.5. South Korea
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. South Korea market estimates and forecasts, 2021 - 2033
    • 7.8.6. Thailand
      • 7.8.6.1. Key country dynamics
      • 7.8.6.2. Competitive scenario
      • 7.8.6.3. Regulatory framework
      • 7.8.6.4. Reimbursement scenario
      • 7.8.6.5. Thailand market estimates and forecasts, 2021 - 2033
  • 7.9. Latin America
    • 7.9.1. Brazil
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement scenario
      • 7.9.1.5. Brazil market estimates and forecasts, 2021 - 2033
    • 7.9.2. Argentina
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. Argentina market estimates and forecasts, 2021 - 2033
  • 7.10. MEA
    • 7.10.1. South Africa
      • 7.10.1.1. Key country dynamics
      • 7.10.1.2. Competitive scenario
      • 7.10.1.3. Regulatory framework
      • 7.10.1.4. Reimbursement scenario
      • 7.10.1.5. South Africa market estimates and forecasts, 2021 - 2033
    • 7.10.2. Saudi Arabia
      • 7.10.2.1. Key country dynamics
      • 7.10.2.2. Competitive scenario
      • 7.10.2.3. Regulatory framework
      • 7.10.2.4. Reimbursement scenario
      • 7.10.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
    • 7.10.3. UAE
      • 7.10.3.1. Key country dynamics
      • 7.10.3.2. Competitive scenario
      • 7.10.3.3. Regulatory framework
      • 7.10.3.4. Reimbursement scenario
      • 7.10.3.5. UAE market estimates and forecasts, 2021 - 2033
    • 7.10.4. Kuwait
      • 7.10.4.1. Key country dynamics
      • 7.10.4.2. Competitive scenario
      • 7.10.4.3. Regulatory framework
      • 7.10.4.4. Reimbursement scenario
      • 7.10.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. List of Distributors
  • 8.4. Vendor Landscape
    • 8.4.1. List of key distributors and channel partners
    • 8.4.2. Key customers
    • 8.4.3. Region wise key company market share analysis, 2025
    • 8.4.4. Hollister Incorporated
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Coloplast
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Boston Scientific Corporation
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. B. Braun SE
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Teleflex Incorporated
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Baxter
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Fresenius Medical Care AG & Co.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Asahi Kasei Corporation
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Cook Group
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Terumo Corporation
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. Nipro Medical Corporation
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. BD
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Product benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. Olympus
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Product benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. Allium Medical
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Product benchmarking
      • 8.4.17.4. Strategic initiatives
    • 8.4.18. Pnn Medical A/S
      • 8.4.18.1. Company overview
      • 8.4.18.2. Financial performance
      • 8.4.18.3. Product benchmarking
      • 8.4.18.4. Strategic initiatives
    • 8.4.19. Merit Medical Systems (BioLife Plasma Services)
      • 8.4.19.1. Company overview
      • 8.4.19.2. Financial performance
      • 8.4.19.3. Product benchmarking
      • 8.4.19.4. Strategic initiatives
    • 8.4.20. Convatec
      • 8.4.20.1. Company overview
      • 8.4.20.2. Financial performance
      • 8.4.20.3. Product benchmarking
      • 8.4.20.4. Strategic initiatives
    • 8.4.21. Ur24Technology, Inc.
      • 8.4.21.1. Company overview
      • 8.4.21.2. Financial performance
      • 8.4.21.3. Product benchmarking
      • 8.4.21.4. Strategic initiatives
    • 8.4.22. Sterimed Group
      • 8.4.22.1. Company overview
      • 8.4.22.2. Financial performance
      • 8.4.22.3. Product benchmarking
      • 8.4.22.4. Strategic initiatives
    • 8.4.23. Wellspect HealthCare, a Dentsply Sirona Company
      • 8.4.23.1. Company overview
      • 8.4.23.2. Financial performance
      • 8.4.23.3. Product benchmarking
      • 8.4.23.4. Strategic initiatives
    • 8.4.24. Boehringer Laboratories, LLC
      • 8.4.24.1. Company overview
      • 8.4.24.2. Financial performance
      • 8.4.24.3. Product benchmarking
      • 8.4.24.4. Strategic initiatives
    • 8.4.25. Medline Industries, LP.
      • 8.4.25.1. Company overview
      • 8.4.25.2. Financial performance
      • 8.4.25.3. Product benchmarking
      • 8.4.25.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. North America nephrology & urology devices, by country, 2021 - 2033 (USD Million)
  • Table 4. North America nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 5. North America nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 6. North America nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 7. U.S. nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 8. U.S. nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 9. U.S. nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 10. Canada nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 11. Canada nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 12. Canada nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 13. Mexico nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 14. Mexico nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 15. Mexico nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 16. Europe nephrology & urology devices, by country, 2021 - 2033 (USD Million)
  • Table 17. Europe nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 18. Europe nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 19. Europe nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 20. UK nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 21. UK nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 22. UK nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 23. Germany nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 24. Germany nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 25. Germany nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 26. France nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 27. France nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 28. France nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 29. Italy nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 30. Italy nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 31. Italy nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 32. Spain nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 33. Spain nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 34. Spain nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 35. Denmark nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 36. Denmark nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 37. Denmark nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 38. Sweden nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 39. Sweden nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 40. Sweden nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 41. Norway nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 42. Norway nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 43. Norway nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 44. Asia Pacific nephrology & urology devices, by country, 2021 - 2033 (USD Million)
  • Table 45. Asia Pacific nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 46. Asia Pacific nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 47. Asia Pacific nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 48. China nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 49. China nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 50. China nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 51. Japan nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 52. Japan nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 53. Japan nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 54. India nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 55. India nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 56. India nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 57. South Korea nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 58. South Korea nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 59. South Korea nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 60. Australia nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 61. Australia nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 62. Australia nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 63. Thailand nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 64. Thailand nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 65. Thailand nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 66. Latin America nephrology & urology devices, by country, 2021 - 2033 (USD Million)
  • Table 67. Latin America nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 68. Latin America nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 69. Latin America nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 70. Brazil nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 71. Brazil nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 72. Brazil nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 73. Argentina nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 74. Argentina nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 75. Argentina nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 76. Middle East & Africa nephrology & urology devices, by country, 2021 - 2033 (USD Million)
  • Table 77. Middle East & Africa nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 78. Middle East & Africa nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 79. Middle East & Africa nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 80. Saudi Arabia nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 81. Saudi Arabia nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 82. Saudi Arabia nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 83. South Africa nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 84. South Africa nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 85. South Africa nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 86. UAE nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 87. UAE nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 88. UAE nephrology & urology devices, by end use, 2021 - 2033 (USD Million)
  • Table 89. Kuwait nephrology & urology devices, by product, 2021 - 2033 (USD Million)
  • Table 90. Kuwait nephrology & urology devices, by application, 2021 - 2033 (USD Million)
  • Table 91. Kuwait nephrology & urology devices, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Nephrology & urology devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product outlook (USD Million)
  • Fig. 10 Application outlook (USD Million)
  • Fig. 11 End use outlook (USD Million)
  • Fig. 12 Competitive landscape
  • Fig. 13 Nephrology & urology devices market dynamics
  • Fig. 14 Nephrology & urology devices market: Porter's five forces analysis
  • Fig. 15 Nephrology & urology devices market: PESTLE analysis
  • Fig. 16 Nephrology & urology devices market: Product segment dashboard
  • Fig. 17 Nephrology & urology devices market: Product market share analysis, 2025 & 2033
  • Fig. 18 Ureteral catheters market, 2021 - 2033 (USD Million)
  • Fig. 19 Intermittent catheters market, 2021 - 2033 (USD Million)
  • Fig. 20 Foley / indwelling catheters market, 2021 - 2033 (USD Million)
  • Fig. 21 External catheters market, 2021 - 2033 (USD Million)
  • Fig. 22 PCN catheters market, 2021 - 2033 (USD Million)
  • Fig. 23 Urinary stents market, 2021 - 2033 (USD Million)
  • Fig. 24 Metallic ureteral stents market, 2021 - 2033 (USD Million)
  • Fig. 25 Polymer ureteral stents market, 2021 - 2033 (USD Million)
  • Fig. 26 Silicone stents market, 2021 - 2033 (USD Million)
  • Fig. 27 Polyurethane stents market, 2021 - 2033 (USD Million)
  • Fig. 28 Hybrid stents market, 2021 - 2033 (USD Million)
  • Fig. 29 Stone basket market, 2021 - 2033 (USD Million)
  • Fig. 30 Disposable stone basket market, 2021 - 2033 (USD Million)
  • Fig. 31 Reusable stone basket market, 2021 - 2033 (USD Million)
  • Fig. 32 Urology guidewires market, 2021 - 2033 (USD Million)
  • Fig. 33 Nitinol guidewires market, 2021 - 2033 (USD Million)
  • Fig. 34 Stainless steel guidewires market, 2021 - 2033 (USD Million)
  • Fig. 35 PTFE guidewires market, 2021 - 2033 (USD Million)
  • Fig. 36 Other guidewires market, 2021 - 2033 (USD Million)
  • Fig. 37 Renal dilators market, 2021 - 2033 (USD Million)
  • Fig. 38 Disposable renal dilators market, 2021 - 2033 (USD Million)
  • Fig. 39 Reusable renal dilators market, 2021 - 2033 (USD Million)
  • Fig. 40 Other products market, 2021 - 2033 (USD Million)
  • Fig. 41 Nephrology & urology devices market: Application segment dashboard
  • Fig. 42 Nephrology & urology devices market: Application market share analysis, 2025 & 2033
  • Fig. 43 Urolithiasis market, 2021 - 2033 (USD Million)
  • Fig. 44 Urological cancer & BPH market, 2021 - 2033 (USD Million)
  • Fig. 45 Bladder disorders market, 2021 - 2033 (USD Million)
  • Fig. 46 Kidney diseases market, 2021 - 2033 (USD Million)
  • Fig. 47 Other applications market, 2021 - 2033 (USD Million)
  • Fig. 48 Nephrology & urology devices market: End-use segment dashboard
  • Fig. 49 Nephrology & urology devices market: End-use market share analysis, 2025 & 2033
  • Fig. 50 Hospitals market, 2021 - 2033 (USD Million)
  • Fig. 51 Clinics market, 2021 - 2033 (USD Million)
  • Fig. 52 Ambulatory surgical centers market, 2021 - 2033 (USD Million)
  • Fig. 53 Other end use market, 2021 - 2033 (USD Million)
  • Fig. 54 Nephrology & urology devices market revenue, by region
  • Fig. 55 Regional marketplace: Key takeaways
  • Fig. 56 Regional marketplace: Key takeaways
  • Fig. 57 North America nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 58 U.S. country dynamics
  • Fig. 59 U.S. nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 60 Canada country dynamics
  • Fig. 61 Canada nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 62 Mexico country dynamics
  • Fig. 63 Mexico nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 64 Europe nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 65 UK country dynamics
  • Fig. 66 UK nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 67 Germany country dynamics
  • Fig. 68 Germany nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 69 France country dynamics
  • Fig. 70 France nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 71 Italy country dynamics
  • Fig. 72 Italy nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 73 Spain country dynamics
  • Fig. 74 Spain nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 75 Denmark country dynamics
  • Fig. 76 Denmark nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 77 Sweden country dynamics
  • Fig. 78 Sweden nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 79 Norway country dynamics
  • Fig. 80 Norway nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 81 Asia Pacific nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 82 Japan country dynamics
  • Fig. 83 Japan nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 84 China country dynamics
  • Fig. 85 China nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 86 India country dynamics
  • Fig. 87 India nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 88 Australia country dynamics
  • Fig. 89 Australia nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 90 South Korea country dynamics
  • Fig. 91 South Korea nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 92 Thailand country dynamics
  • Fig. 93 Thailand nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 94 Latin America nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 95 Brazil country dynamics
  • Fig. 96 Brazil nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 97 Argentina country dynamics
  • Fig. 98 Argentina nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 99 Middle East & Africa nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 100 South Africa country dynamics
  • Fig. 101 South Africa nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 102 Saudi Arabia country dynamics
  • Fig. 103 Saudi Arabia nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 104 UAE country dynamics
  • Fig. 105 UAE nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 106 Kuwait country dynamics
  • Fig. 107 Kuwait nephrology & urology devices market, 2021 - 2033 (USD Million)
  • Fig. 108 Company categorization
  • Fig. 109 Company market position analysis
  • Fig. 110 Strategic framework